Modulating EGFR-MTORC1-autophagy as a potential therapy for persistent fetal vasculature (PFV) disease. [electronic resource]
Producer: 20210512Description: 1130-1142 p. digitalISSN:- 1554-8635
- Animals
- Astrocytes -- drug effects
- Autophagy -- drug effects
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Cells, Cultured
- Disease Models, Animal
- ErbB Receptors -- antagonists & inhibitors
- Eye -- metabolism
- Gefitinib -- pharmacology
- Lysosomes -- drug effects
- Mechanistic Target of Rapamycin Complex 1 -- antagonists & inhibitors
- Microscopy, Immunoelectron
- Morpholines -- pharmacology
- Persistent Hyperplastic Primary Vitreous -- genetics
- Rats
- Signal Transduction -- genetics
- Sirolimus -- pharmacology
- beta-Crystallin A Chain -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.